Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression
- PMID: 33860906
- DOI: 10.1007/s11065-021-09502-7
Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression
Abstract
Mild cognitive changes, including executive dysfunction, are seen in Parkinson's Disease (PD). Approximately 30% of individuals with PD develop Parkinson's disease dementia (PDD). Mild cognitive impairment (MCI) has been identified as a transitional state between normal cognition and dementia. Although PD-MCI and its cognitive correlates have been increasingly studied as a risk indicator for development of PDD, investigations into the PD-MCI construct have yielded heterogeneous findings. Thus, a typical PD-MCI cognitive profile remains undefined. The present meta-analysis examined published cross-sectional studies of PD-MCI and cognitively normal PD (PD-CN) groups to provide aggregated effect sizes of group test performance by cognitive domain. Subsequently, longitudinal studies examining PD-MCI to PDD progression were meta-analyzed. Ninety-two cross-sectional articles of PD-MCI vs. PD-CN were included; 5 longitudinal studies of PD-MCI conversion to PDD were included. Random effects meta-analytic models were constructed resulting in effect sizes (Hedges' g) for cognitive domains. Overall performance across all measures produced a large effect size (g = 0.83, 95% CI [0.79, 0.86], t2 = 0.18) in cross-sectional analyses, with cognitive screeners producing the largest effect (g = 1.09, 95% CI [1.00, 1.17], t2 = 0.19). Longitudinally, overall measures produced a moderate effect (g = 0.47, 95% CI [0.40, 0.53], t2 = 0.01), with measures of executive functioning exhibiting the largest effect (g = 0.70, 95% CI [0.51, 0.89], t2 = 0.01). Longitudinal effects were made more robust by low heterogeneity. This report provides the first comprehensive meta-analysis of PD-MCI cognitive outcomes and predictors in PD-MCI conversion to PDD. Limitations include heterogeneity of cross-sectional effect sizes and the potential impact of small-study effects. Areas for continued research include visuospatial skills and visual memory in PD-MCI and longitudinal examination of executive dysfunction in PD-MCI.
Keywords: Cognition; Dementia; Mild cognitive impairment; Parkinson’s disease.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.Int J Geriatr Psychiatry. 2015 Oct;30(10):1048-55. doi: 10.1002/gps.4261. Epub 2015 Feb 11. Int J Geriatr Psychiatry. 2015. PMID: 25676160
-
Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.J Parkinsons Dis. 2022;12(6):1749-1782. doi: 10.3233/JPD-223238. J Parkinsons Dis. 2022. PMID: 35599499
-
Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.J Clin Exp Neuropsychol. 2016;38(1):40-50. doi: 10.1080/13803395.2015.1087465. Epub 2015 Nov 25. J Clin Exp Neuropsychol. 2016. PMID: 26602176
-
Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.J Neurol Neurosurg Psychiatry. 2014 Jan;85(1):7-16. doi: 10.1136/jnnp-2013-305062. Epub 2013 Jul 4. J Neurol Neurosurg Psychiatry. 2014. PMID: 23828835
-
A systematic review and meta-analysis on the association between orthostatic hypotension and mild cognitive impairment and dementia in Parkinson's disease.Neurol Sci. 2023 Apr;44(4):1211-1222. doi: 10.1007/s10072-022-06537-3. Epub 2022 Dec 21. Neurol Sci. 2023. PMID: 36542202
Cited by
-
Mild cognitive impairment in dementia with Lewy bodies: an update and outlook.J Neural Transm (Vienna). 2023 Dec;130(12):1491-1508. doi: 10.1007/s00702-023-02670-1. Epub 2023 Jul 7. J Neural Transm (Vienna). 2023. PMID: 37418039 Review.
-
Memory Deficits in Parkinson's Disease Are Associated with Impaired Attentional Filtering and Memory Consolidation Processes.J Clin Med. 2023 Jul 10;12(14):4594. doi: 10.3390/jcm12144594. J Clin Med. 2023. PMID: 37510708 Free PMC article.
-
Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson's disease patients.J Neural Transm (Vienna). 2023 May;130(5):687-696. doi: 10.1007/s00702-023-02624-7. Epub 2023 Mar 28. J Neural Transm (Vienna). 2023. PMID: 36976351
-
Cataract surgery utilization in Parkinson's disease: the english longitudinal survey on ageing.Graefes Arch Clin Exp Ophthalmol. 2024 Mar;262(3):865-870. doi: 10.1007/s00417-023-06314-8. Epub 2023 Nov 10. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37947822 Free PMC article.
-
Reliable change indices for the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson's disease patients.BMC Neurol. 2024 Nov 4;24(1):427. doi: 10.1186/s12883-024-03920-9. BMC Neurol. 2024. PMID: 39497078 Free PMC article.
References
-
- Aarsland, D., Andersen, K., Larsen, J. P., & Lolk, A. (2003). Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology, 60(3), 387–392.
-
- Agosta, F., Canu, E., Stefanova, E., Sarro, L., Tomić, A., Špica, V., & Filippi, M. (2014). Mild cognitive impairment in Parkinson’s disease is associated with a distributed pattern of brain white matter damage. Human Brain Mapping, 35(5), 1921–1929. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical